Assessing evidence of interaction between smoking and warfarin: A systematic review and meta-analysis

Chest

Volumn 139, Issue 5, 2011, Pages 1130-1139

  Nathisuwan, Surakit ^a   Dilokthornsakul, Piyameth ^b   Chaiyakunapruk, Nathorn ^b,c,d   Morarai, Tatiya ^b   Yodting, Thararat ^b   Piriyachananusorn, Nichakorn ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NARESUAN UNIVERSITY   (Thailand)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; POLYCYCLIC AROMATIC HYDROCARBON; WARFARIN;

ADULT; AGED; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE INCREASE; DRUG HALF LIFE; DRUG MONITORING; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; OUTCOME ASSESSMENT; PHARMACOGENOMICS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SENSITIVITY ANALYSIS; SMOKING; SYSTEMATIC REVIEW;

EID: 79955749858     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-0777     Document Type: Review

References (29)

1. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G; American College of Chest Physicians. The pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines 8th ed. Chest. 2008;133(6 suppl):160S-198S.
2. Hirsh J, Fuster V, Ansell J, Halperin JL; American Heart Association; American College of Cardiology Foundation. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation. 2003;107(12):1692-1711.
3. Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005;165(10):1095-1106. (Pubitemid 40720733)
4. Kroon LA. Drug interactions with smoking. Am J Health Syst Pharm. 2007;64(18):1917-1921. (Pubitemid 47462906)
5. Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet. 1999;36(6):425-438.
6. Bachmann K, Shapiro R, Fulton R, Carroll FT, Sullivan TJ. Smoking and warfarin disposition. Clin Pharmacol Ther. 1979;25(3):309-315. (Pubitemid 9181039)
7. Colucci VJ, Knapp JF. Increase in international normalized ratio associated with smoking cessation. Ann Pharmacother. 2001;35(3):385-386. (Pubitemid 32201727)
8. Whitley HP, Fermo JD, Chumney ECG, Brzezinski WA. Effect of patient-specific factors on weekly warfarin dose. Ther Clin Risk Manag. 2007;3(3):499-504. (Pubitemid 47214991)
9. Reichert J, Araújo AJ, Gonçalves CMC, et al; Sociedade Brasileira de Pneumologia e Tisiologia. Smoking cessation guidelines - 2008. J Bras Pneumol. 2008;34(10):845-880.
10. US Department of Health and Human Services. Clinical Prac tice Guideline: Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD : US Department of Health and Human Services, Public Health Service;2008.
11. Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ. 1994;309(6965):1351-1355. (Pubitemid 24345976)
12. Deeks JJ, Higging JPT, Altman DG. Analysis and undertaking meta-analyses. In: Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, England: John Wiley & Sons; 2008.
13. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558. (Pubitemid 34746062)
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188. (Pubitemid 17189972)
15. Begg CB, Berlin JA. Publication bias and dissemination of clinical research. J Natl Cancer Inst. 1989;81(2):107-115. (Pubitemid 19031327)
16. Egger M, Smith GD. Bias in location and selection of studies. BMJ. 1998;316(7124):61-66.
17. Aquilante CL, Langaee TY, Lopez LM, et al. Influence of coagulation factor, vitamin K epoxide reductase complex sub-unit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements. Clin Pharmacol Ther. 2006;79(4):291-302.
18. Gage BF, Eby C, Johnson JA, et al. Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clin Pharmacol Ther. 2008;84(3):326-331.
19. Lee VWY, You JHS, Lee KKC, Chau TS, Waye MM, Cheng G. Factors affecting the maintenance stable warfarin dosage in Hong Kong Chinese patients. J Thromb Thrombolysis. 2005;20(1):33-38. (Pubitemid 41300619)
20. Lenzini PA, Grice GR, Milligan PE, et al. Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients. J Thromb Haemost. 2008;6(10):1655-1662.
21. Millican EA, Lenzini PA, Milligan PE, et al. Genetic-based dosing in orthopedic patients beginning warfarin therapy. Blood. 2007;110(5):1511-1515. (Pubitemid 47443966)
22. University of Illinois at Chicago. Cigarette smoking: Its effect on warfarin dosing and on the pk of warfarin enantiomers. Formulary. 1999;34(10):873-874.
23. Mungall DR, Ludden TM, Marshall J, Hawkins DW, Talbert RL, Crawford MH. Population pharmacokinetics of racemic warfarin in adult patients. J Pharmacokinet Biopharm. 1985; 13(3):213-227. (Pubitemid 16194622)
24. Mitchell AA. Smoking and warfarin dosage. N Engl J Med. 1972;287(22):1153-1154.
25. Weiner B, Faraci PA, Fayad R, Swanson L. Warfarin dosage following prosthetic valve replacement: effect of smoking history. Drug Intell Clin Pharm. 1984;18(11):904-906. (Pubitemid 15219218)
26. McGriff-Lee NJ, Csako G, Chen JT, et al; Anticoagulation Working Group. Search for predictors of nontherapeutic INR results with warfarin therapy. Ann Pharmacother. 2005;39(12):1996-2002.
27. Pamboukian SV, Nisar I, Patel S, et al. Factors associated with non-adherence to therapy with warfarin in a population of chronic heart failure patients. Clin Cardiol. 2008; 31(1): 30-34.
28. Evans M, Lewis GM. Increase in international normalized ratio after smoking cessation in a patient receiving warfarin. Pharmacotherapy. 2005;25(11):1656-1659. (Pubitemid 41566925)
29. Kuykendall JR, Houle MD, Rhodes RS. Possible warfarin failure due to interaction with smokeless tobacco. Ann Pharmacother. 2004;38(4):595-597. (Pubitemid 38352220)